GlobalData on MSN3d
SkylineDx study highlights value in combined myeloma diagnostic approach
SkylineDx’s SKY92 test with fluorescence in situ hybridisation testing led to more accurate identification of high-risk ...
Finanznachrichten6d
SKYLINEDX ANNOUNCES NEW PUBLICATION ON SKY92 GENE EXPRESSION PROFILING TEST in DEFINING ULTRA-HIGH-RISK MULTIPLE MYELOMA
ROTTERDAM, the Netherlands and SAN DIEGO, Feb. 28, 2025 /PRNewswire/ -- SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for ...
Medical Device Network3d
SkylineDx study highlights value in combined myeloma diagnostic approach
Image credit: OGphoto via Getty Images. SkylineDx has published a new study marking a “significant advancement” in the understanding and identification of high-risk (HR) multiple myeloma (MM) patients ...